Aurobindo to acquire Lannett Company for Rs. 2,185 Cr
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
The company has projected Rs. 5,630 crores of investment and to provide employment to 6,350 people in three phases over a period of eight years
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Prasad has played a key role in shaping Dr. Reddy’s into a globally respected organisation
The inspection was conducted from July 22-25, 2025
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to make critical drugs
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Subscribe To Our Newsletter & Stay Updated